The Cancer Predisposition Program at the Aflac Cancer and Blood Disorders Center of Children's treats children under the age of 18 who are at risk for developing cancer due to a cancer predisposition syndrome, a family history of cancer or a diagnosis of a rare type of cancer.
What is a cancer predisposition syndrome?
A cancer predisposition syndrome is when an individual is born with a genetic mutation (or change) that increases his or her baseline risk for developing cancer. Estimates say that 10 percent of all pediatric cancers are caused by a cancer predisposition syndrome.
Through the cancer predisposition program of the Aflac Cancer and Blood Disorders Center, we provide a multidisciplinary approach, incorporating comprehensive, pediatric-focused genetic counseling and cutting edge genetic tools to ensure the highest level of care for each patient and their family.
We are one of the largest pediatric cancer predisposition programs in the Southeast and the only center in Georgia.
We provide services to more than 100 patients and family members who are at risk for developing cancer because of a family history and/or mutations in cancer predisposition genes.
We are No. 4 in Children's Oncology Group (COG) therapeutic clinical trial enrollment.